The mutation frequencies of TP53 (47%), TTN (45%), KMT2D (29%), MUC16 (27%) and KDM6A were the 5 most common IRGs in BLCA (Fig. 1A). This evidence concerns the gene KMT2D and bladder transitional cell carcinoma.